B. Metzler seel. Sohn & Co »

Immunovant shares owned by B. Metzler seel. Sohn & Co

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by B. Metzler seel. Sohn & Co from 13F filings

Historical chart of B. Metzler seel. Sohn & Co investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by B. Metzler seel. Sohn & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by B. Metzler seel. Sohn & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $586k 18k 32.31

More positions owned by B. Metzler seel. Sohn & Co

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Procter & Gamble Company (PG)
Coca-Cola Company (KO)
UnitedHealth (UNH)
Thermo Fisher Scientific (TMO)
Johnson & Johnson (JNJ)
Palo Alto Networks (PANW)
S&p Global (SPGI)
Deere & Company (DE)
BlackRock (BLK)

View all positions for B. Metzler seel. Sohn & Co

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Perceptive Advisors
Armistice Capital
T. Rowe Price Associates
Viking Global Investors
Logos Global Management
Alpine Partners VI
Point72 Asset Management
Geode Capital Management
Woodline Partners
Fred Alger Management
Pictet Asset Management Holding SA
Rock Springs Capital Management

View all funds holding Immunovant